Literature DB >> 21674703

Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.

Shadi Sepehri1, Ehsan Khafipour, Charles N Bernstein, Brian K Coombes, Ana V Pilar, Mohamed Karmali, Kim Ziebell, Denis O Krause.   

Abstract

BACKGROUND: Mucosal-associated Escherichia coli may play a role in the pathogenesis of inflammatory bowel diseases (IBDs). In this study we assessed mucosal-associated E. coli in adults at the time of first diagnosis.
MATERIALS AND METHODS: E. coli were isolated from 59 right colon biopsies of 34 newly diagnosed adult IBD patients (Crohn's disease [CD] = 23, ulcerative colitis [UC] = 11) and 25 healthy controls (HC). Strains were serotyped, phylotyped into A, B1, B2, or D, and tested for their ability to survive in macrophages. The presence of various virulence factors was also assessed. The fimH subunit of type 1 fimbriae was sequenced and phylogenetically analyzed.
RESULTS: A total of 65 E. coli were isolated from CD (29 isolates from 23 patients), UC (11 isolates from 11 patients), and HC (25 isolates from 25 subjects). All E. coli were positive for fimH, crl, and cgsA and negative for vt1, vt2, hlyA, cnf, and eae. Significant positive associations were between CD and in between CD and afae (P = 0.002), and between UC and ompA (P = 0.02), afae (P = 0.03), and USP (P = 0.04). The B2+D phylotype was significantly associated with inflammation (P = 0.04) as it was with serine protease autotransporters (SPATE), malX, ompA, and kpsMTII (P < 0.05). Macrophage survival was the highest in UC-isolated E. coli (P = 0.04). FimH amino acid substitutions N91S, S99N, and A223V were associated with IBD (P < 0.05).
CONCLUSIONS: Adherent invasive E. coli are present at first diagnosis, suggesting that they may have a role in the early stages of disease onset.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21674703     DOI: 10.1002/ibd.21509

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  33 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; Karen A Krogfelt; Beth A McCormick
Journal:  Cell Microbiol       Date:  2011-10-27       Impact factor: 3.715

Review 3.  Use of antibiotics in the treatment of Crohn's disease.

Authors:  Maria Lia Scribano; Cosimo Prantera
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

4.  Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli.

Authors:  Joseph B McPhee; Cherrie L Small; Sarah A Reid-Yu; John R Brannon; Hervé Le Moual; Brian K Coombes
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

Review 5.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

6.  Analysis of Escherichia coli isolated from patients affected by Crohn's disease.

Authors:  Tiziana Raso; Sabrina Crivellaro; Maria Gabriella Chirillo; Paolo Pais; Ezio Gaia; Dianella Savoia
Journal:  Curr Microbiol       Date:  2011-05-28       Impact factor: 2.188

Review 7.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.

Authors:  Ines Zollner-Schwetz; Kathrin A T Herzog; Gebhard Feierl; Eva Leitner; Georg Schneditz; Hanna Sprenger; Jürgen Prattes; Wolfgang Petritsch; Heimo Wenzl; Patrizia Kump; Gregor Gorkiewicz; Ellen Zechner; Christoph Högenauer
Journal:  Dig Dis Sci       Date:  2015-06-20       Impact factor: 3.199

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells.

Authors:  Anna Negroni; Eleonora Colantoni; Roberta Vitali; Francesca Palone; Maria Pierdomenico; Manuela Costanzo; Vincenzo Cesi; Salvatore Cucchiara; Laura Stronati
Journal:  Inflamm Res       Date:  2016-06-22       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.